首页> 外文期刊>Colorectal cancer. >Predicting response to treatment for colorectal cancer: a review of relevant mechanisms and potential biomarkers
【24h】

Predicting response to treatment for colorectal cancer: a review of relevant mechanisms and potential biomarkers

机译:预测对结直肠癌治疗的反应:相关机制和潜在生物标志物的综述

获取原文
获取原文并翻译 | 示例
       

摘要

Neoadjuvant therapy for colorectal cancer offers potential oncological benefits but is associated with increased surgical risk. Predictive biomarkers would allow the personalization of this risk/benefit balance, with treatment stratified by likely response. Although current clinical application of predictive biomarkers is limited, a number of potential targets have been proposed. This review summarizes some of the approaches being used to develop predictive biomarkers for the personalization of colorectal cancer management.
机译:大肠癌的新辅助疗法具有潜在的肿瘤学益处,但与手术风险增加相关。预测性生物标记物将使这种风险/益处平衡的个性化,并根据可能的反应对治疗进行分层。尽管预测性生物标志物的当前临床应用受到限制,但是已经提出了许多潜在的靶标。这篇综述总结了一些用于开发预测性生物标志物以结直肠癌治疗个性化的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号